Adaptive Biotechnologies Corporation Common Stock (ADPT) is a publicly traded Healthcare sector company. As of October 17, 2026, ADPT trades at $24.02 with a market cap of $4.08B and a P/E ratio of -64.65. ADPT moved -6.06% today. Year to date, ADPT is +48.55%; over the trailing twelve months it is +39.09%. Its 52-week range spans $6.26 to $30.74. Analyst consensus is strong buy with an average price target of $29.36. Rallies surfaces ADPT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ADPT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $24.02 |
| Market Cap | $4.08B |
| P/E Ratio | -64.65 |
| EPS | $-0.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $30.74 |
| 52-Week Low | $6.26 |
| Volume | 1.63M |
| Avg Volume | 0 |
| Revenue (TTM) | $308.08M |
| Net Income | $-63.99M |
| Gross Margin | 75.57% |
9 analysts cover ADPT: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.36.